Actual Medicinal Product (AMP) Glucophage SR 500mg tablets (Mawdsley-Brooks & Company Ltd)
This product can't be added to an MCA list.
Stability Information
(Some stability information inherited from generic)
- Stability
-
Lack of data and/or stability concerns exist. MCA use may be acceptable but is likely to be off-label and require mitigation measures. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.
- Notes
-
Light sensitive medicine. Store in light resistant container. No stability data in MCAs available.
- Provenance
-
This recommendation is based on the products Glucophage SR 500mg prolonged-release tablets (Merck) and Sukkarto SR 500mg prolonged-release tablets (Morningside Healthcare Ltd).
- Generic
- Metformin
- Formulation
- Metformin 500mg modified-release tablets
-
Metformin
-
Metformin 500mg modified-release tablets
-
Glucophage SR 500mg tablets (Mawdsley-Brooks & Company Ltd)
-
-
Metformin 850mg capsules